Formulation Licenses
Registered finished dosage forms (FDF), transferable tech packages and in-development in-licensing pipelines · delivered per target-market approval pathway
Licensing pipeline
UB713
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB713)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
UB712
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB712)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB711
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB711)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB710
—
- Therapy
- Others > Anesthesiology
- Status
- Candidate licensing (UB710)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
UB709
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB709)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB708
—
- Therapy
- Cardiovascular
- Status
- Candidate licensing (UB708)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States
Licensing pipeline
PTH*RANKL
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB706)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
PTH
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB705)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
IGF-1R
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB704)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
GHR
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB703)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
CDH17*CEA
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB702)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
TP53 Y220C
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB701)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
FRα*FRα
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB700)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
PSMA*B7H3
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB699)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
APRIL*BAFF
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB698)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
PD1+ T-cell depleter
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB697)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
SLC6A19
—
- Therapy
- Nephrology & Urology
- Status
- Candidate licensing (UB696)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
VEGF A/C/D*Ang2
—
- Therapy
- Ophthalmology
- Status
- Candidate licensing (UB695)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
TSHR
—
- Therapy
- Ophthalmology
- Status
- Candidate licensing (UB694)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
CFTR
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB693)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
MMP7
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB692)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
CTGF
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB691)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
MUC5AC
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB690)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
RAGE
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB689)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
IL1β*IL1α
—
- Therapy
- Others > Women's Health
- Status
- Candidate licensing (UB688)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
Gardnerella
—
- Therapy
- Others > Women's Health
- Status
- Candidate licensing (UB687)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
NK3R
—
- Therapy
- Others > Women's Health
- Status
- Candidate licensing (UB686)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB684
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB684)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB683
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB683)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
TF
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB681)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
EGFRVIII/CD3
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB680)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
MSLN/CD3
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB679)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
CD155
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB678)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
EPO
—
- Therapy
- Nephrology & Urology
- Status
- Candidate licensing (UB677)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
IL-15
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB676)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China, United States
Licensing pipeline
CTLA 4/CD 28/PD-L1/PD-L2
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB675)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China, United States
Licensing pipeline
VEGF
—
- Therapy
- Ophthalmology
- Status
- Candidate licensing (UB674)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
IL-7; HSA
—
- Therapy
- Infectious Diseases
- Status
- Candidate licensing (UB673)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB672
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB672)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB671
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB671)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB670
—
- Therapy
- Ophthalmology
- Status
- Candidate licensing (UB670)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB669
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB669)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB668
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB668)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
Liver
—
- Therapy
- Others > Hematology
- Status
- Candidate licensing (UB667)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB666
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB666)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
GLP-1/GIP/GCG/FGF21
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB665)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
GLP-1
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB664)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
EGFR/HER2
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB663)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China